Nivolumab Plus Ipilimumab Wins European Approval for MSI-H/dMMR mCRC
Nivolumab plus ipilimumab has been approved in Europe for the frontline treatment of adult patients with MSI-H or dMMR metastatic colorectal cancer.
Related Articles
Updates: MSK – Anthem Blue Cross Insurance Contract Negotiations
Stay updated with the latest on the MSK and Anthem Blue Cross insurance negotiations to keep Memorial Sloan Kettering Cancer Center as an in-network provider.
Middle East crisis live: Israel orders closure of one of last functioning hospitals in northern Gaza
Head of Kamal Adwan hospital says it is ‘next to impossible’ to obey shut down order due to lack of ambulances to evacuate patients
Prophylactic Tocilizumab Reduces Toxicity, Boosts Efficacy in Immune Checkpoint Inhibitor–Treated Melanoma
Matthew Hadfield, DO, discusses findings from a phase 2 study that used tocilizumab to reduce toxicities with immune checkpoint inhibitors in melanoma.
How to make transplanted stem cells feel at home
In this issue of Blood, Verkamp and colleagues1 present a retrospective analysis of the emapalumab (anti-interferon gamma [IFN-γ] monoclonal antibody) use
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial | JCO Oncology Practice
PURPOSERemote symptom monitoring of patients with cancer has previously shown potential for improving clinical outcomes. This study aimed to evaluate the effects of remote symptom…
Myasthenia Gravis Research Highlights: AAN 2024
Nicholas Silvestri, MD, of the Univ of Buffalo, provides an overview of the latest myasthenia gravis clinical research presented at AAN 2024.
Childhood Cancer Data Initiative (CCDI)
The Childhood Cancer Data Initiative addresses the critical need to collect, analyze, and share data to speed up progress against childhood cancer.
Highlights of ASH in the Mediterranean, Middle East, and North Africa
Join the world’s leading hematology experts at Highlights of ASH in the Mediterranean, Middle East, and North Africa, a two-day program that highlights the most…
Osteosarcoma Spheroid Models Provide Key Tool for Preclinical Drug Development
R. Lor Randall, MD, FACS, discusses the construction and preclinical utility of spheroid models for drug development in osteosarcoma.
Become a Member Today
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals…
